Skip to main content
. 2022 Jan 25;12(2):159. doi: 10.3390/brainsci12020159

Table A2.

Demographics of sexual dysfunctions in detail.

Total Female Male Significance
Erectile Dysfunction
N 152 152
% responders 69.7% 69.7%
% men with SD 57.6% 57.6%
Age at diagnosis
(years)
N 148 148
Median [IQR] 58 (23–26,28,55–64) 58 (23–26,28,55–64)
Disease duration
(years)
N 147 147
Median [IQR] 7 (4–11) 7 (4–11)
Orgasm dysfunction
N 84 84
% responders 50.9% 50.9%
% women with SD 46.8% 46.8%
Age at diagnosis
(years)
N 77 77
Median [IQR] 56 (23–28,55–62) 56 (23–28,55–62)
Disease duration
(years)
N 77 77
Median [IQR] 5 (3–9) 5 (3–9)
Difficulties in becoming sexually aroused
N 185 71 111 ns
% responders 47.7% 43.0% 50.9%
% total with SD 43.2% 39.4% 42.0%
Age at diagnosis
(years)
N 174 63 109
Median [IQR] 58 (23–26,28,55–63) 57 (23–26,28,55–62) 59 (24–26,55–64) ns
Disease duration
(years)
N 174 63 109
Median [IQR] 5 (3–9) 5 (3–8) 6 (4–11) ns
Unable to relax and enjoy sex
N 177 68 106 ns
% responders 45.5% 41.0% 48.6%
% total with SD 41.4% 37.8% 40.2%
Age at diagnosis
(years)
N 164 60 102
Median [IQR] 57 (23–26,28,55–63) 55 (23–28,55–61) 59 (23–26,28,55–64) ns
Disease duration
(years)
N 164 60 102
Median [IQR] 5 (3–10) 5 (3–9) 6 (4–11) ns
Lack of sexual interest
N 174 81 91 Χ2 < 0.05 *
% responders 44.2% 48.0% 41.4%
% total with SD 40.65% 45.0% 34.5%
Age at diagnosis
(years)
N 163 73 89
Median [IQR] 57 (23–28,55–62) 55 (23–30,55–60) 58 (23–26,28,55–64) p < 0.05 *
Disease duration
(years)
N 163 73 89
Median [IQR] 5 (3–10) 5 (3–9) 6 (3–12) ns
Increased libido
N 74 19 55 Χ2 < 0.0001 *
% responders 18.9% 11.2% 25.0%
% total with SD 17.3% 4.4% 12.9%
Age at diagnosis
(years)
N 73 19 54
Median [IQR] 57 (23–28,55–61) 56 (23–26,28,55–62) 57 (23–28,55–60) ns
Disease duration
(years)
N 71 19 52
Median [IQR] 7 (4–10) 4 (3–10) 7 (4–11) ns
Compulsive sexual urges
N 68 13 55 Χ2 < 0.0001 *
% responders 11.3% 6.7% 17.7%
% total with SD 15.9% 3.0% 12.9%
Age at diagnosis
(years)
N 65 12 53
Median [IQR] 55 (23–30,54–64) 52 (23–30,52–56) 56 (23–28,30,55–65) ns
Disease duration
(years)
N 63 12 51
Median [IQR] 9 (4–13) 7 (3–9) 9 (5–13) ns

IQR, interquartile range, N, number of patients; ns, not significant; * Significant correlation at p < 0.05; statistical test: chi square test.